Tokyo Tape
Sign in
← BrightPath Biotherapeutics

Quarterly report · Q2

4594.TEDINET S100PKLP
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥179,0002022-04-01 → 2022-09-30StandaloneNet sales
Revenue¥15m2021-04-01 → 2022-03-31StandaloneNet sales (5-year summary)
Revenue¥263,0002021-04-01 → 2021-09-30StandaloneNet sales
Operating income−¥805m2022-04-01 → 2022-09-30StandaloneOperating income
Operating income−¥721m2021-04-01 → 2021-09-30StandaloneOperating income
Ordinary income−¥810m2022-04-01 → 2022-09-30StandaloneOrdinary income
Ordinary income−¥1.5bn2021-04-01 → 2022-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥723m2021-04-01 → 2021-09-30StandaloneOrdinary income
Profit before tax−¥810m2022-04-01 → 2022-09-30StandaloneIncome before income taxes
Profit before tax−¥723m2021-04-01 → 2021-09-30StandaloneIncome before income taxes
Net income−¥811m2022-04-01 → 2022-09-30StandaloneProfit loss
Net income−¥1.5bn2021-04-01 → 2022-03-31StandaloneNet income loss (5-year summary)
Net income−¥724m2021-04-01 → 2021-09-30StandaloneProfit loss
Total assets¥2.1bnat 2022-09-30StandaloneAssets
Total assets¥2.8bnat 2022-03-31StandaloneAssets
Total assets¥3.2bnat 2021-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥111mat 2022-09-30StandaloneLiabilities
Total liabilities¥240mat 2022-03-31StandaloneLiabilities
Net assets / equity¥2.0bnat 2022-09-30StandaloneNet assets
Net assets / equity¥2.5bnat 2022-03-31StandaloneNet assets
Net assets / equity¥3.0bnat 2021-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.9bnat 2022-09-30StandaloneCash and deposits
Cash and deposits¥2.3bnat 2022-03-31StandaloneCash and deposits
Cash & equivalents¥1.9bnat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥2.3bnat 2022-03-31StandaloneCash and cash equivalents
Cash & equivalents¥2.7bnat 2021-09-30StandaloneCash and cash equivalents
Cash & equivalents¥3.3bnat 2021-03-31dStandaloneCash and cash equivalents
Operating cash flow−¥589m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.5bn2021-04-01 → 2022-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥752m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥18m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥11m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥197m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥569m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥229m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-14.22022-04-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-4.522022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-28.552021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-14.22021-04-01 → 2021-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.272021-07-01 → 2021-09-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio93.8%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.5%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio94.2%at 2021-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued58,903,100at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued55,253,100at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued52,368,000at 2021-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 344
ItemContextValueUnit
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember805202000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-721471000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-805068000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember14000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember11000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember44000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember546000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember59000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember557000JPY
Foreign exchange losses noePrior1YTDDuration_NonConsolidatedMember618000JPY
Foreign exchange losses noeCurrentYTDDuration_NonConsolidatedMember4146000JPY
Stock issuance cost noePrior1YTDDuration_NonConsolidatedMember1430000JPY
Stock issuance cost noeCurrentYTDDuration_NonConsolidatedMember1073000JPY
Other noePrior1YTDDuration_NonConsolidatedMember－JPY
Other noeCurrentYTDDuration_NonConsolidatedMember61000JPY
Non operating expensesPrior1YTDDuration_NonConsolidatedMember2049000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember5281000JPY
Ordinary incomePrior1YTDDuration_NonConsolidatedMember-723461000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember-809792000JPY
Gain on reversal of subscription rights to shares eiPrior1YTDDuration_NonConsolidatedMember4455000JPY
Gain on reversal of subscription rights to shares eiCurrentYTDDuration_NonConsolidatedMember－JPY
Extraordinary incomePrior1YTDDuration_NonConsolidatedMember4455000JPY
Extraordinary incomeCurrentYTDDuration_NonConsolidatedMember－JPY
Impairment loss elPrior1YTDDuration_NonConsolidatedMember3667000JPY
Impairment loss elCurrentYTDDuration_NonConsolidatedMember－JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration_NonConsolidatedMember37000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration_NonConsolidatedMember－JPY
Extraordinary lossPrior1YTDDuration_NonConsolidatedMember3704000JPY
Extraordinary lossCurrentYTDDuration_NonConsolidatedMember－JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember-722710000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-809792000JPY
Income taxes currentPrior1YTDDuration_NonConsolidatedMember1210000JPY
Income taxes currentCurrentYTDDuration_NonConsolidatedMember950000JPY
Income taxesPrior1YTDDuration_NonConsolidatedMember1210000JPY
Income taxesCurrentYTDDuration_NonConsolidatedMember950000JPY
Profit lossPrior1YTDDuration_NonConsolidatedMember-723920000JPY
Profit lossCurrentYTDDuration_NonConsolidatedMember-810742000JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember-722710000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-809792000JPY
Depreciation and amortization ope cfPrior1YTDDuration_NonConsolidatedMember16934000JPY
Depreciation and amortization ope cfCurrentYTDDuration_NonConsolidatedMember8359000JPY
Impairment loss ope cfPrior1YTDDuration_NonConsolidatedMember3667000JPY
Impairment loss ope cfCurrentYTDDuration_NonConsolidatedMember－JPY
Gain on reversal of subscription rights to shares ope cfPrior1YTDDuration_NonConsolidatedMember-4455000JPY
Gain on reversal of subscription rights to shares ope cfCurrentYTDDuration_NonConsolidatedMember－JPY
Loss on retirement of noncurrent assets ope cfPrior1YTDDuration_NonConsolidatedMember37000JPY
Loss on retirement of noncurrent assets ope cfCurrentYTDDuration_NonConsolidatedMember－JPY
Interest and dividends income ope cfPrior1YTDDuration_NonConsolidatedMember－JPY
Interest and dividends income ope cfCurrentYTDDuration_NonConsolidatedMember-11000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration_NonConsolidatedMember227000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2022-03-31pass
balance sheet identitynon_consolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2021-04-01/2021-09-30pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass